ARCHIVES

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

This article is from The Cancer Letter archive.

Vol. 15 No. 32 | August 11, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Grant Funding Payline To Begin At 16th Percentile In FY 2010

December 11, 2009

Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says

June 6, 2003

CSR Draft Report Proposes New Panel To Review Clinical Oncology Research

February 20, 1998

This month’s 8-page Business & Regulatory Report included in this issue.

January 30, 2004

AACR Changes Its Logo— For The Fifth Time Since 2000

July 11, 2014

“NCI activities at Frederick are not well integrated…. It would be wise to reorganize and consolidate.”

July 21, 1995